AQR Capital Management
LENZ

AQR Capital Management’s LENZ Therapeutics LENZ Stock Holding History

AQR Capital Management’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Buy
+140,305
New +$1.97M ﹤0.01% 2636

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

AQR Capital Management's LENZ Position: Q1 2026 in Review

AQR Capital Management opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 140,305 shares worth $1.28M. The stake represents ﹤0.01% of the portfolio and ranks #2636 among its holdings.

145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • AQR Capital Management held 140,305 shares of LENZ Therapeutics worth $1.28M as of Q1 2026.
  • LENZ Therapeutics was a new AQR Capital Management position in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2636 holding.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.